Atlas Trials

Lymphoma, Large-Cell, Diffuse

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lymphoma, Large-Cell, Diffuse

RecordFirmDate
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma (NCT01014208)GlaxoSmithKline2010-03-01
Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT00823719)GlaxoSmithKline2009-05-01
Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant (NCT00622388)GlaxoSmithKline2007-12-01
CT-011 MAb in DLBCL Patients Following ASCT (NCT00532259)CureTech Ltd2007-10-01
A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma (NCT00498043)Hospices Civils de Lyon2007-07-01
Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects (NCT00498914)Astellas Pharma Inc2007-06-01
Chemotherapy for Participants With Lymphoma (NCT00436280)Eli Lilly and Company2007-02-01
Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL (NCT00379574)Asan Medical Center2006-09-01
PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma (NCT00511043)David Rizzieri, MD2005-11-01
Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab (NCT00561379)Nantes University Hospital2005-04-01
R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma (NCT00137995)Lymphoma Study Association2003-06-01
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies (NCT00514722)University of California, San Francisco2002-10-01
R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma (NCT00135499)Lymphoma Study Association2001-10-16
ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma (NCT00169130)Lymphoma Study Association1999-10-01
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas (NCT00001237)National Cancer Institute (NCI)1989-03-01

Track Lymphoma, Large-Cell, Diffuse automatically

Every clearance here is in the API, with alerts when new ones post.